Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 87.5 +1 (+1.16%) Jul 24
At Loss
P/B:
15.64
Market Cap:
€ 7.80B ($ 8.87B)
Enterprise V:
€ 7.28B ($ 8.28B)
Volume:
208.00
Avg Vol (2M):
119.00
Trade In:

Spyre Therapeutics Inc Valuation Measures